Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Integrative Analysis of MUC4 to Prognosis and Immune Infiltration in Pan-Cancer: Friend or Foe?

16 Jul 2021

Abstract excerpt

MUC4, a transmembrane mucin, plays important roles in epithelial renewal and differentiation. Recent studies suggest that MUC4 has been implicated in pancreatic cancer pathogenesis and is expressed in various normal and cancer tissues. The underlying features of MUC4 across various cancer types may allow us to ensure appropriate treatment and patient monitoring. However, the contributions of MUC4 to pan-cancer...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Galectins and Cancer Biology
Share to Glycosylation and Glycoproteins Research
Share to Monoclonal and Polyclonal Antibodies Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34336844
DOI: 10.3389/fcell.2021.695544

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Integrative Analysis of MUC4 to Prognosis and Immune Infiltration in Pan-Cancer: Friend or Foe?PMID 34336844Read ↗

Integrative analysis of the cancer genome atlas and cancer cell lines encyclopedia large-scale genomic databases: MUC4/MUC16/MUC20 signature is associated with poor survival in human carcinomasSemantic proximity Read ↗

Expression signature, prognosis value, and immune characteristics of MUC1 identified by pan-cancer analysisSemantic proximity Read ↗

MUCIN-4 (MUC4) is a novel tumor antigen in pancreatic cancer immunotherapy.Semantic proximity Read ↗

Mucins in human neoplasms: Clinical pathology, gene expression and diagnostic applicationSemantic proximity Read ↗

Comprehensive Analysis of Clinical Prognosis and Molecular Immune Characterization of TPM4 in Pancreatic CancerSemantic proximity Read ↗

A Pan-Cancer Analysis of the Oncogenic Role of Integrin Beta4 (ITGB4) in Human TumorsSemantic proximity Read ↗

Muc4/MUC4 Functions and Regulation in CancerSemantic proximity Read ↗

MicroRNA-150 directly targets MUC4 and suppresses growth and malignant behavior of pancreatic cancer cellsSemantic proximity Read ↗

Prognostic Value of MUC1 and its Correlation with Tumor-Infiltrating Immune Cells in Breast CancerSemantic proximity Read ↗

CGB5 Proves to be a Promising Predictive and Immunotherapeutic Indicator across Pan-CancerSemantic proximity Read ↗

Structure, evolution, and biology of the MUC4 mucinSemantic proximity Read ↗

Multi-omics pan-cancer study of SPTBN2 and its value as a potential therapeutic target in pancreatic cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.